NCM
TERN icon

NEXTBio Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

NEXTBio Capital Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-604,534
Closed -$31.9M – 27
2026
Q1 		$31.9M Buy
604,534
+53,344
+10% +$2.19M 14.8% 1
2025
Q4 		$22.3M Buy
+551,190
New +$12.7M 13.06% 1

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

NEXTBio Capital Management's TERN Position: Q2 2026 in Review

NEXTBio Capital Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 604,534 shares — an estimated $31.9M sold.

NEXTBio Capital Management first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $31.9M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • NEXTBio Capital Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • NEXTBio Capital Management sold 604,534 Terns Pharmaceuticals shares in Q2 2026, an estimated $31.9M.
  • NEXTBio Capital Management first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • NEXTBio Capital Management's Terns Pharmaceuticals position peaked at $31.9M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on NEXTBio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.